Free Trial
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

NeurAxis logo
$3.20 -0.79 (-19.80%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$3.06 -0.15 (-4.53%)
As of 09:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeurAxis Stock (NASDAQ:NRXS)

Key Stats

Today's Range
$3.00
$3.44
50-Day Range
$1.62
$3.99
52-Week Range
$1.33
$6.20
Volume
3.15 million shs
Average Volume
396,524 shs
Market Capitalization
$23.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Receive NRXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

NRXS Stock News Headlines

NeurAxis, Inc. Announces $5 Million Stock Offering
Here’s your answer
Porter Stansberry is stepping into the spotlight — and putting real skin in the game. For the first time ever, he’s opening the doors to a live, real-money trading account, managed transparently with the same strategies he’s used to build long-term wealth. Every 90 days, he and his lead analyst release a new tranche of trades designed for serious investors who don’t want to babysit the market. The goal: income, downside protection, and asymmetric upside.
Best Penny Stocks To Research - May 20th
NeurAxis Announces $5.0 Million Registered Direct Offering
See More Headlines

NRXS Stock Analysis - Frequently Asked Questions

NeurAxis' stock was trading at $2.35 at the beginning of the year. Since then, NRXS stock has increased by 36.2% and is now trading at $3.20.
View the best growth stocks for 2025 here
.

NeurAxis, Inc. (NASDAQ:NRXS) announced its earnings results on Tuesday, November, 12th. The company reported ($0.25) earnings per share for the quarter. The company earned $0.67 million during the quarter.

NeurAxis (NRXS) raised $7 million in an initial public offering on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

Top institutional shareholders of NeurAxis include AIGH Capital Management LLC (0.28%).
View institutional ownership trends
.

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), AMMO (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and ETRACS Crude Oil Shares Covered Call ETN (USOI).

Company Calendar

Last Earnings
11/12/2024
Today
5/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NRXS
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,630,000.00
Net Margins
-492.76%
Pretax Margin
-341.35%

Debt

Sales & Book Value

Annual Sales
$2.69 million
Price / Cash Flow
N/A
Book Value
($0.27) per share
Price / Book
-11.85

Miscellaneous

Free Float
6,085,000
Market Cap
$23.09 million
Optionable
Not Optionable
Beta
3.34
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NRXS) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners